Yttrium-90-labeled ibritumomab tiuxetan (Zevalin (R)) for primary CNS lymphoma - Final results of a phase II studyP. Kiewe,A. Korfel,S. Maza,K. Jahnke,D. L. Munz,E. ThielANNALS OF ONCOLOGY（2008）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
